Triptorelin Pamoate
Triptorelin works by first signaling the pituitary gland to release more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which briefly raises testosterone levels. With continued use, the pituitary gland stops making as much LH and FSH, leading to lower testosterone levels over time. This helps slow or stop the growth of prostate cancer cells that need testosterone to grow. It is a type of luteinizing hormone-releasing hormone (LHRH) agonist.
Trelstar Depot
FDA label information for this drug is available at DailyMed.
Use in Cancer
Triptorelin pamoate is approved to treat prostate cancer that is advanced.
Triptorelin pamoate is also being studied in the treatment of other types of cancer.
More About Triptorelin Pamoate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Hormone Therapy for Prostate Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Triptorelin Pamoate - Check for trials from NCI's list of cancer clinical trials now accepting patients.